
Dr Mark Gurnell, Addenbrooke’s Hospital, Cambridge
This project was initiated and funded by Teva Respiratory. Teva have had no influence over content. Topics and content have been selected and written by independent experts.
Please let us know if you are a healthcare professional or a member of the public so that we can point you in the right direction.
Dr Mark Gurnell recaps his presentation as part of the 2019 Fresh Approaches meeting on the impact on patients of long-term use of corticosteriods.
Dr Mark Gurnell, Addenbrooke’s Hospital, Cambridge
This project was initiated and funded by Teva Respiratory. Teva have had no influence over content. Topics and content have been selected and written by independent experts.
The link you have clicked on will open in a new tab.
Do you wish to continue?